Taylor & Francis Group

SHERPA: Unknown

People

  1. Giralt
    Giralt
  2. Zelenetz
    Zelenetz
  3. Tallman
    Tallman
  4. Horwitz
    Horwitz
  5. Hassoun
    Hassoun
  6. Landau
    Landau
  7. Yahalom
    Yahalom
  8. Devlin
    Devlin
  9. Hay
    Hay
  10. Moskowitz
    Moskowitz

Groups

  1. Department of Medicine (390)
  2. Hematologic Malignancies, Division of (281)
  3. Center for Hematologic Malignancies (272)
  4. Survivorship Research (175)
  5. Population Sciences Research Program (138)
  6. Psychiatry and Behavioral Sciences, Department of (117)
  7. GSK Faculty (105)
  8. Lymphoma (92)
  9. Solid Tumor Oncology Division (91)
  10. Adult Leukemia (87)
Search Within
Formats
  1. Journal Article (782)
  2. Book Section (62)
  3. Review (62)
  4. Meeting Abstract (41)
  5. Editorial (21)
  6. Research Letter (18)
  7. Correspondence (11)
  8. Conference Paper (9)
  9. Book Whole (4)
  10. Guidelines (2)
Groups
  1. Department of Medicine (390)
  2. Hematologic Malignancies, Division of (281)
  3. Center for Hematologic Malignancies (272)
  4. Survivorship Research (175)
  5. Population Sciences Research Program (138)
  6. Psychiatry and Behavioral Sciences, Department of (117)

More Groups

People
  1. Sergio Giralt (35)
  2. Andrew Zelenetz (31)
  3. Martin Tallman (28)
  4. Steven Horwitz (23)
  5. Philip Bialer (22)
  6. Hani Hassoun (21)

More People

Years
  1. 2025 (34)
  2. 2024 (46)
  3. 2023 (39)
  4. 2022 (52)
  5. 2021 (45)
  6. 2020 (54)

More Years

Publications
  1. Leukemia and Lymphoma (314)
  2. Expert Review of Anticancer Therapy (69)
  3. Journal of Psychosocial Oncology (59)
  4. Women's Oncology Review (35)
  5. Cancer Biology and Therapy (28)
  6. Atlas of Procedures in Breast Cancer Surgery (24)

More Publications

Results (1012)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Corticosteroid tapering is a safe approach in patients with relapsed or refractory multiple myeloma receiving subcutaneous daratumumab: Part 3 of the open-label, multicenter, phase 1b PAVO study
    Research Letter

    Nahi, H.; Usmani, S. Z.; Mateos, M. V.; van de Donk, N. W. C. J.; Oriol, A.; Plesner, T.; Bandyopadhyay, N.; Hellemans, P.; Tromp, B.; Nnane, I.; more...
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • Activating STAT5B mutations can cause both primary hypereosinophilia and lymphocyte-variant hypereosinophilia
    Research Letter

    Umrau, K.; Naganuma, K.; Gao, Q.; Dogan, A.; Kizaki, M.; Roshal, M.; Liu, Y.; Yabe, M.
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • Cognition in patients treated with targeted therapy for chronic myeloid leukemia: A controlled comparison
    Journal Article

    Hyland, K. A.; Eisel, S. L.; Hoogland, A. I.; Root, J. C.; Bowles, K.; James, B.; Nelson, A. M.; Booth-Jones, M.; Jacobsen, P. B.; Ahles, T. A.; more...
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • Time to second treatment can be used to predict overall survival in chronic lymphocytic leukemia: Identifying risk factors to help guide treatment selection
    Journal Article

    Bantilan, K. S.; Kay, N. E.; Parikh, S. A.; Rabe, K. G.; Call, T. G.; Leis, J. F.; Ding, W.; Slager, S. L.; Soumerai, J. D.; Roeker, L. E.; more...
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • Safety and efficacy of combinatorial therapy utilizing myeloablative conditioning and autologous stem cell transplantation, targeted immunotherapy, and reduced intensity conditioning and allogeneic stem cell transplantation in children, adolescents, and young adults with relapsed/refractory mature B-cell non-Hodgkin lymphoma
    Research Letter

    Gardenswartz, A.; Mehta, B.; El-Mallawany, N. K.; van de Ven, C.; Hochberg, J.; Flower, A.; Morris, E.; Harrison, L.; Chu, Y.; Basso, J.; more...
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • Venetoclax-based salvage therapy in patients with relapsed/refractory acute myeloid leukemia previously treated with FLT3 or IDH1/2 inhibitors
    Journal Article

    Bewersdorf, J. P.; Shallis, R. M.; Derkach, A.; Goldberg, A. D.; Stein, A.; Stein, E. M.; Marcucci, G.; Zeidan, A. M.; Shimony, S.; DeAngelo, D. J.; more...
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • Characterization and management of adverse events observed with mobocertinib (TAK-788) treatment for EGFR exon 20 insertion–positive non–small cell lung cancer
    Review

    Yang, J. C. H.; Zhou, C.; Jänne, P. A.; Ramalingam, S. S.; Kim, T. M.; Riely, G. J.; Spira, A. I.; Piotrowska, Z.; Mekhail, T.; Garcia Campelo, M. R.; more...
    Expert Review of Anticancer Therapy (2023)

    Fulltext@MSK | Save
  • NDUFA4L2 reduces mitochondrial respiration resulting in defective lysosomal trafficking in clear cell renal cell carcinoma
    Journal Article

    Kubala, J. M.; Laursen, K. B.; Schreiner, R.; Williams, R. M.; van der Mijn, J. C.; Crowley, M. J.; Mongan, N. P.; Nanus, D. M.; Heller, D. A.; Gudas, L. J.
    Cancer Biology and Therapy (2023)

    Fulltext@MSK | Save
  • Developing an ACT-based intervention to address lung cancer stigma: Stakeholder recommendations and feasibility testing in two NCI-designated cancer centers
    Journal Article

    Kaplan, D. M.; Hamann, H. A.; Price, S. N.; Williamson, T. J.; Ver Hoeve, E. S.; McConnell, M. H.; Duchschere, J. E.; Garland, L. L.; Ostroff, J. S.
    Journal of Psychosocial Oncology (2023)

    Fulltext@MSK | Save
  • Cohort profile - MSK radiation workers: A feasibility study to establish a deceased worker sub-cohort as part of a multicenter medical radiation worker component in the million person study of Low-Dose radiation health effects
    Journal Article

    Dauer, L. T.; Woods, M.; Miodownik, D.; Serencsits, B.; Quinn, B.; Bellamy, M.; Yoder, C.; Liang, X. L.; Boice, J. D.; Bernstein, J.
    International Journal of Radiation Biology (2022)

    Fulltext@MSK | Save